Genome mining has become a key technology to explore and exploit natural product diversity through the identification and analysis of biosynthetic gene clusters (BGCs). Initially, this was performed on a single-genome basis; currently, the process is being scaled up to large-scale mining of pan-genomes of entire genera, complete strain collections and metagenomic datasets from which thousands of bacterial genomes can be extracted at once. However, no bioinformatic framework is currently available for the effective analysis of datasets of this size and complexity. Here, we provide a streamlined computational workflow, tightly integrated with antiSMASH and MIBiG, that consists of two new software tools, BiG-SCAPE and CORASON. BiG-SCAPE facilitates rapid calculation and interactive visual exploration of BGC sequence similarity networks, grouping gene clusters at multiple hierarchical levels, and includes a 'glocal' alignment mode that accurately groups both complete and fragmented BGCs. CORASON employs a phylogenomic approach to elucidate the detailed evolutionary relationships between gene clusters by computing high-resolution multi-locus phylogenies of all BGCs within and across gene cluster families (GCFs), and allows researchers to comprehensively identify all genomic contexts in which particular biosynthetic gene cassettes are found. We validate BiG-SCAPE by correlating its GCF output to metabolomic data across 403 actinobacterial strains. Furthermore, we demonstrate the discovery potential of the platform by using CORASON to comprehensively map the phylogenetic diversity of the large detoxin/rimosamide gene cluster clan, prioritizing three new detoxin families for subsequent characterization of six new analogs using isotopic labeling and analysis of tandem mass spectrometric data.
Introduction
Microbial specialized metabolites are key mediators of interspecies communication and competition in the environment and in the context of host microbiomes 1, 2 . Their diverse chemical structures have been critical in the development of antibiotics, anticancer drugs, crop protection agents and ingredients for manufacturing. While tens of thousands of natural products have been discovered in past decades, recent evidence suggests that these represent a fraction of the potential natural product chemical space yet to be discovered [3] [4] [5] [6] [7] [8] .
Genome mining has emerged in the past decade as a key technology to explore and exploit natural product diversity. Key to this success is the fact that genes encoding natural product biosynthetic pathways are usually clustered together on the chromosome. These biosynthetic gene clusters (BGCs) can be readily identified in a genome. Moreover, in many cases, the chemical structures of their products can be predicted to a certain extent, based on the analysis and biosynthetic logic of the enzymes encoded in a BGC and their similarity to known counterparts 9 .
Initially, genome mining was performed on a single-genome basis: a research group or consortium would sequence the genome of a single microbial strain and attempt to identify and characterize each of its BGCs one by one. This approach has revealed much about the metabolic capacities of model natural-product-producing organisms like Streptomyces coelicolor, Sorangium cellulosum and Aspergillus nidulans and has provided clues regarding the discovery potential from corresponding genera [10] [11] [12] . Computational tools for the identification of BGCs and the prediction of their products' chemical structures, such as antiSMASH [13] [14] [15] [16] and PRISM [17] [18] [19] , have played a key role in the success of genome mining. These in silico approaches have been strengthened by comparative analysis of identified BGCs with rich empirical reference data, such as those provided by the MIBiG community effort, which has documented (meta)data on >1,000 BGCs connected to their products 20 .
biosynthetic potential of broad taxonomic groups of organisms, as well as entire ecosystems. These large-scale analyses easily lead to the identification of thousands of BGCs with varying degrees of mutual similarity, ranging from widely distributed homologs of gene clusters for the production of well-known molecules to rare or unique gene clusters that encode unknown enzymes and pathways.
To map and prioritize this complex biosynthetic diversity, several groups have devised methods to compare architectural relationships between BGCs in sequence similarity networks and group them into gene cluster families (GCFs), each of which contains BGCs across a range of organisms that are linked to a highly similar natural product chemotype 4,28,29, . The presence or expression of such GCFs can be correlated to molecular families (MFs) identified from mass spectrometry data to match genes to their product molecules in a process termed metabologenomics 4, 30, 31 . However, current methods fail to correctly measure similarity between complete and fragmented gene clusters (which frequently occur in metagenomes and large-scale pan-genome sequencing projects based on short-read technologies); do not consider the complex and multi-layered evolutionary relationships within and between GCFs; require lengthy CPU-time on supercomputers when processing large datasets; and lack a user-friendly implementation that interacts directly with other key resources. These shortcomings preclude adoption by the broader scientific community and impede significant advances in natural product discovery.
Here, we provide a streamlined computational workflow that tightly integrates two new software tools, BiG-SCAPE and CORASON, with the gene cluster identification and empirical biosynthetic data comparison possible through antiSMASH 16 and MIBiG 20 (Fig 1) . BiG-SCAPE facilitates rapid calculation and interactive exploration of BGC sequence similarity networks (SSNs); it accounts for differences in modes of evolution between BGC classes, groups gene clusters at multiple hierarchical levels (families, clans and classes), introduces a 'glocal' alignment mode that supports complete as well as fragmented BGCs, and democratizes the analysis through a dramatically accelerated and interactive stand-alone user interface. As a complement to this, CORASON employs a phylogenomic approach to elucidate detailed evolutionary relationships between gene clusters by computing high-resolution multi-locus phylogenies of all BGCs within and across GCFs. Additionally, it allows researchers to comprehensively identify all genomic contexts in which gene cassettes of interest, which encode a specific function within a BGC, can be found. To validate the GCF classifications, we show that metabologenomic correlations accurately connect genes to mass features across metabolomic data from 363 strains. Furthermore, we demonstrate the power of the combined workflow, together with the EvoMining algorithm 8 , to comprehensively map diversity within gene cluster clans by identifying three new families responsible for the biosynthesis of new detoxins. A streamlined algorithm for large-scale network analysis and classification of biosynthetic gene clusters To provide a streamlined, scalable and user-friendly software for exploring and classifying large collections of gene clusters, we built the Biosynthetic Gene Similarity Clustering and Prospecting Engine (BiG-SCAPE), written in Python and freely available as open source software (https://git.wageningenur.nl/medema-group/BiG-SCAPE). BiG-SCAPE takes BGCs predicted by antiSMASH or annotated in MIBiG as inputs to automatically generate sequence similarity networks and assemble GCFs. In previous studies by Cimermancic et al. 3 and Doroghazi et al. 4 , two sets of distance metrics had been independently developed to measure the (dis)similarity of pairs of BGCs. In BiG-SCAPE, we aimed to combine the respective strengths of both approaches. The strength of the former approach was the elegant compression of gene clusters into strings of Pfam domains, combined with the Jaccard index (JI) to measure domain content similarity (Fig 2a) Fig. 2b and Table S5 ). In the output, separate networks are generated for each BiG-SCAPE class, along with an optional overall network that combines BGCs from all classes. Another problem of previous approaches for calculating distances between BGCs was how to handle comparisons between complete and partial BGCs (e.g., from fragmented genome assemblies), as well as comparisons with pairs of genomically adjacent BGCs that are merged into one cluster by antiSMASH or other cluster identification tools. Both global similarity (used in all previous methods) and local similarity lead to artifacts in such cases. To compare the appropriate corresponding regions between BGCs, we introduced a new 'glocal' alignment mode, which first uses a fast algorithm to find the longest common substring between the Pfam strings of a BGC pair, and then uses match/mismatch penalties to extend the alignment until the end of the matching region (Fig. 2c , Online Methods). Information about whether an antiSMASH 16 -annotated cluster is located at the edge of a contig can also be used to automatically select a third pairwise distance calculation mode that relies on global alignment for complete clusters and glocal alignment when at least one of the BGCs in a pair is fragmented. BGC sequence similarity networks are then generated by applying a cut-off to the distance matrix calculated by BiG-SCAPE, while rounds of affinity propagation clustering 34 are used to group BGCs into GCFs, and GCFs into "Gene Cluster Clans" (GCCs). This process of categorization facilitates calculating metabologenomic correlations 35, 36 at multiple levels.
Results & Discussion
Results can be further processed in downstream analysis or immediately visualized using an interactive HTML-based interface that permits dynamic exploration of the gene cluster network (see further below for more details). 
Validation using natural product chemical similarity networks and large-scale metabolomics data
To verify that BiG-SCAPE is able to group together BGCs that are known to be related, we constructed a chemical similarity network from all products of BGCs in MIBIG, and used this to derive a curated set of 376 compounds, which were manually classified into 92 groups (e.g. 14-membered macrolides, benzoquinone ansamycins, quinomycin antibiotics etc.) and 9 classes (e.g. Polyketides, NRPs, RiPPs etc.). We then used BiG-SCAPE to group the corresponding BGCs into GCFs and observed good correspondence between manually curated families and those predicted by BiG-SCAPE ( Supplementary Fig S5) .
Arguably, the greatest value of BiG-SCAPE lies in the practical utility of the predicted GCFs for discovery applications. Hence, we assessed the accuracy of correlations of BiG-SCAPE-predicted GCFs to MS ions from known natural product through metabologenomics 31 . First, we performed a BiG-SCAPE analysis of 74,652 BGCs from 3,080 actinobacterial genomes (see Methods), including 1,393 reference BGCs from MIBiG 20 . BiG-SCAPE grouped these BGCs into a total number of 17,718 GCFs and 801 GCCs using default parameters. Extracts from 363 actinomycete strains were analyzed using untargeted high-resolution LC-MS/MS 4 . The GCF annotations for these 363 strains from two BiG-SCAPE modes (global and glocal) at two similarity cutoffs (0.30 and 0.50) were used to generate four rounds of metabologenomic correlations utilizing a binary scoring metric as described previously 4, 30 . BiG-SCAPE's gene cluster family annotations were then assessed against ion production patterns via two methods. First, a 'golden dataset' of nine known ion signals and their characterized gene clusters were manually tracked across the four correlation rounds. These ion signals corresponded to the following natural products; CE-108, benarthin, desertomycin, tambromycin, enterocin, tyrobetaine, chlortetracycline, rimosamide, and oxytetracycline. Second, a target-decoy approach was applied to estimate the false discovery rate (FDR) for each round to provide an overview of correlative power for the unknown ion to gene cluster family hypotheses generated (see Fig. S14 ). Decoy databases used for the target-decoy
dataset ion-GCF pairs observed above a 1% FDR at 0.30 and 0.50 glocal similarity score cutoffs, respectively. Based on the BGCs and molecules observed in the above data, gene cluster networks and molecular networks were generated. Exploration of these networks highlighted high diversity in both gene clusters and molecules, exemplified by the identification of 152 different BGCs (at <0.95 overall similarity) related to known detoxin/rimosamide gene clusters (Fig. 3b) , and 110 different molecules related to detoxins and rimosamides (Fig. 3c) . 
dotted outlines. c, Histogram of all ion-GCF correlation scores resulting from a metabologenomics round run with 0.30 glocal similarity score cutoffs. Known ion-GCF pair correlation scores are overlaid, with tyrobetaine, chlortetracycline, rimosamide, and oxytetracycline ion-GCF pairs identified above a 1% FDR threshold. Fig. 4 | CORASON Workflow. a, Given a query gene in a reference cluster and a custom genomic annotated database, CORASON i) searches for query gene homologues, ii) creates the Cluster Variation Database (CVD) by filtering out all genomic vicinities not related to the reference BGC, including keeping fragmented clusters and iii) calculates the CVD gene core by multi bidirectional best hits. b, Then, CORASON infers a phylogenetic tree by curation and concatenation of the CVD gene core, and displays the CVD following the tree and calculates the frequency of occurrence for each gene family from the reference BGC. c, With the same reference BGC, if a new query gene is selected from accessory enzymes instead of the current CVD core, CORASON will visualize a new phylogeny with families containing the same molecular modifications, expanding the chemical universe within an evolutionary framework.
Multi-locus gene cluster phylogenies resolve evolutionary relationships between related BGCs
Genetic diversity of BGCs within GCFs is directly related to structural differences between their molecular products, and even small chemical variations can lead to different biological activities 37 .
Hence, mapping the evolutionary relationships between BGCs within and across GCFs is crucial for the discovery process. To this end, we introduce the CORe Analysis of Syntenic Orthologues to prioritize Natural products biosynthetic gene clusters (CORASON) software, written in Perl and available as open source from https://github.com/nselem/corason. Given a query gene inside a BGC of interest, the CORASON pipeline identifies other genomic loci that contain homologues of this gene and calculates a multi-locus phylogeny of all loci based on their conserved core (Fig. 4) .
CORASON is available for users as a downloadable and easy-to-install software that allows tracing the evolutionary history of biosynthetic genes using customizable databases. Any subset of genes from a BGC may be selected to identify other genomic contexts across a set of prokaryotic genomes in which homologues of these genes are found. The selected query genes are then visualized on a multi-locus approximate-maximum-likelihood phylogenetic tree 46 that allows the user to identify all functional genomic contexts in which the corresponding gene families are found. In this way, the evolutionary relationships of each gene within a BGC across large numbers of genomes can be comprehensively analyzed. A version of the CORASON algorithm, called 'familymode', was also integrated with BiG-SCAPE, allowing to generate a multi-locus phylogeny of all BGCs within each GCF using the sequences of their common domain core.
An integrated workflow and interactive visualization allow rapid exploration of biosynthetic diversity
BiG-SCAPE and CORASON connect seamlessly with antiSMASH and MIBiG, as GenBank outputs of antiSMASH can be used directly as inputs for the workflow, and MIBiG reference data can be included in the analysis automatically. Although calculations on hundreds or thousands of genomes are too compute-intensive to provide them on a free public web server, we still wanted to make the results available in an interactive user-friendly HTML visualization that enables efficient exploration of biosynthetic diversity across large datasets for non-programmers. Hence, we constructed a powerful JavaScript-based visualization that provides an interactive output for every BiG-SCAPE run, which can be viewed offline on any web browser. In a single view, the visualization displays BGC nodes colored by GCF in interactive sequence similarity networks, side-by-side with arrow visualizations of the gene clusters, which contain gene annotation and Pfam domain details that appear on mouse-over. Networks can be searched by compound names of MIBiG reference clusters, Pfam domains of interest, or species names, with resulting match nodes instantly highlighted within the network. Each GCF is given its own view panel, which shows the CORASON-based multi-locus phylogeny of the underlying BGCs and includes links to related families within the same GCF. Finally, an overview page is provided that displays statistics on the BGCs identified, as well as a GCF absence/presence heatmap of the most frequently occurring gene clusters within the input dataset.
To illustrate BiG-SCAPE/CORASON usage, we provide an example output of a run with antiSMASH-predicted BGCs from 103 complete Streptomyces genomes, including as outgroups the genomes of Catenulispora acidiphila and Salinispora arenicola: http://bioinformatics.nl/~xnava009/streptomyces_out/. To connect the absence/presence map of GCFs across these genomes to species phylogeny, a high-resolution multilocus whole-genome phylogeny (Fig.S11) was inferred from the Streptomyces conserved-core (Online Data: StreptomycesCore .), and the GCF absence/presence patterns were plotted onto the structure of the tree (Fig. S12) . As has been observed before in other genera like Salinispora 29 , this shows high conservation of select GCFs across larger numbers of genomes, combined with large numbers of rare GCFs that are specific to one or a few genomes.
Identification of novel detoxin/rimosamide analogues using BiG-SCAPE and CORASON
To showcase the power of our workflow for the analysis of large BGC collections and highresolution mapping of GCF biosynthetic diversity, we focused on the detoxin and rimosamide GCFs 38 . Our comprehensive analysis of the selected actinobacterial genomes revealed these BGCs to be taxonomically widespread and architecturally diverse (Fig. 5) . The conserved gene core of detoxin and rimosamide BGCs is composed of three genes: one NRPS, one NRPS/PKS hybrid, and a homologue of tauD, presumably recruited from the tauABCD operon in Escherichia coli 39 . as suggested by EvoMining analysis.
The rimosamide BGC differs from those of the detoxins by having an additional NRPS, which encodes for further elaboration of the common detoxin/rimosamide core scaffold with isobutyrate and glycine 38 . Aside from the more common NRPS and PKS genes, the fact that the tauD gene was present across all members of this family caught our attention. The product of the tauD gene belongs to the Fe(II)/α-ketoglutarate-dependent hydroxylase enzyme superfamily and is named for the commonly encoded α-ketoglutarate-dependent taurine dioxygenase involved in assimilation of sulphite by oxygenolytic release from the amino acid taurine 40 . Interestingly, this family also includes enzymes across fungi, bacteria and plants that catalyze hydroxylations, desaturations, ring expansions, and ring formations, among other transformations. To date, the role of tauD in detoxin and rimosamide biosynthesis is unknown, but it has been suggested to be responsible for the proline oxidation observed in some analogs 38 .
An EvoMining 8 analysis of the TauD dioxygenase protein family showed specific specialized metabolism-related expansions of paralogues across genera such as Streptomyces, Rhodococcus, Frankia and Amycolatopsis (Fig S13) . Within this expansion, one clade was shown to contain fifteen tauD homologues that are part of experimentally characterized BGCs from MIBiG, including the detoxin and rimosamides BGCs (Table S6 ).
To identify novel detoxin and rimosamide-related natural product BGCs, we selected all BGCs containing a tauD homologue. The resulting 1175 gene clusters were then subjected to a combined BiG-SCAPE/CORASON analysis. This revealed that the detoxin and rimosamide GCFs are part of a larger gene cluster clan related to peptide biosynthesis that also comprises unexplored families across the phylum Actinobacteria (Fig 5) . Metabolomic data was available for 40 of the 152 strains identified to encode these BGCs. Tandem mass spectrometry molecular networking analysis of these strains indicated the presence of three known detoxins, four known rimosamides, and 103 putatively novel detoxin and rimosamide analogues (Fig. 3b) , confirming the vast natural product chemical diversity suggested in the BiG-SCAPE/CORASON data.
Based on inspection of genetic features unique to detoxin/rimosamide BGC phylogenetic clades identified by CORASON (Fig. 5 , in red), there were three that captured our interest. The first was named the 'P450/enoyl clade' and contained two P450 genes and an enoyl-CoA hydratase/isomerase within its BGCs. Tandem mass spectrometry analysis of extracts from Streptomyces sp. NRRL S-325, which contains a BGC within this clade, led to the discovery of detoxin S 1 (1; Figs. 5, S15-16) with a heptanamide side chain, a unique feature among the detoxins and rimosamides whose installation likely depends on the enoyl-CoA hydratase/isomerase. The second clade of interest, termed the 'supercluster clade' (Fig. 5 , in light green), comprised BGCs that encode detoxins in a 'supercluster' that included the known spectinomycin BGC. Two detoxin-like BGCs within this clade in the genomic dataset, identified in the genomes of Streptomyces sp. NRRL B-1347 and Actinomycete sp. NRRL B-1348, were syntenic to a spectinomycin BGC (virtually identical to BGC0000715 in MIBiG) in a supercluster configuration (Fig. 5) . Interestingly, the MIBiG spectinomycin cluster was included on the detoxin/rimosamide CORASON tree just beside the BiG-SCAPE-defined supercluster clade due to the presence of a tauD gene at its periphery that is homologous with those from the detoxins. The tauD gene is not known to be involved in spectinomycin biosynthesis, so we hypothesized that the strain from which the MIBiG entry was sourced, Streptomyces spectabilis NRRL 2792, must have a detoxin BGC beside the spectinomycin cluster and would also produce a detoxin-like product. With this, we acquired the producing strain to determine if CORASON analysis was powerful enough to predict metabolite production solely based on the presence of a query gene but in the absence of full genomic data or a complete BGC. Tandem mass spectrometry analysis of a S. spectabilis NRRL 2792 extract revealed production of six detoxin-like natural products, including detoxin N 1 (2; Figs. 5, S17) and its acetoxylated analog, detoxin N 2 (3; Figs. 5, S19). Structural features unique to this novel detoxin subclass included the incorporation and formylation of tyrosine resulting in a formamido group. LC-MS analysis of cultures supplemented with stable isotope-labeled amino acids corroborated these structural predictions based on analysis of the BGC and tandem MS data (Figs. S18, S20).
The third detoxin clade that we targeted occurred almost entirely within the genus Amycolatopsis and was named the 'Amycolatopsis/P450 clade' (Fig. 5, in blue) . This clade drew our interest as its BGCs contained a cytochrome P450 gene unique among the detoxins and rimosamides that was predicted to be responsible for novel hydroxylation patterns. Though we did not have strains in our library with BGCs in the BiG-SCAPE-defined clade, CORASON analysis allowed the selection of a strain with a very similar BGC also containing the desired P450 gene (Fig. 5) . Tandem MS analysis of this strain, Amycolatopsis jejuensis NRRL B-24427, revealed detoxin isomers P 1 (4; Figs. 5, S21) containing a tyrosine, P 2 (5; Figs. 5, S26) featuring a hydroxylated valine, as well as detoxin P 3 , a closely related analog free of hydroxylation (6; Figs. 5, S31). As before, validation of amino acid assignments observed in MS 2 fragmentation data was achieved through several metabolic feeding experiments using stable isotope-labeled amino acids (Figs. S22-S25, S27-S30, and S32). Detailed structural analysis of 1-6, including detailed interpretation of tandem MS spectra and results from feeding studies using stable isotope-labeled amino acids, can be found in the Supporting Information.
Our results show how BiG-SCAPE can effectively identify sets of related BGCs across large numbers of genome sequences. Moreover, using CORASON to systematically map BGC evolutionary diversity and assemble gene cluster phylogenies proved to be a powerful approach for the discovery of novel clades of BGCs that are responsible for the biosynthesis of uncharted natural product chemistry. When focused toward the specific detoxin/rimosamide discovery effort in "query mode," CORASON guided the discovery of six new detoxins by way of tauD phylogeny. Thus, CORASON enables rapid mapping and visualization of BGC relationships for more effective genome mining from large genomic libraries. Additionally, variation in BGC domain architecture corresponded to variation in chemical structure -presence of an enoyl-CoA hydratase/isomerase corresponded to the fatty acid amide detoxin S 1 and presence of a unique P450 gene corresponded to evidence of hydroxylations in detoxins P 1 -P 3 . Some highly similar BGCs and those that were the most remote from the BiG-SCAPE-defined clades were removed from the original tree for readability. The representative structures for each clade illustrate the correspondence between molecular and genomic variations. The BGC tree is rooted with a TauD encoded in an unrelated (non-NRPS) BGC from Streptomyces sp. NC1. The genes encoding the NRPS, the NRPS/PKS hybrid, and the TauD homologue are highly conserved among detoxin and rimosamide BGCs. Highlighted sections on the tree indicate BiG-SCAPE-defined clades. Bolded strain/BGC names are those investigated in this study with dotted lines indicating those which were just outside the BiG-SCAPE-defined clades. Clusters in the 'P450/enoyl clade' contain a pair of P450 genes and an enoyl-CoA hydratase/isomerase which are putatively involved in biosynthesis of alkylated detoxins, the 'supercluster clade' is comprised of detoxin clusters and is immediately adjacent a spectinomycin BGC, and the 'Amycolatopsis/P450 clade' possess a unique P450 enzyme that corresponds to the first examples of hydroxylation in the detoxin/rimosamide class. Strain names are followed by their Genbank accession number when available. Genes not found in the reference cluster are colored based on BLAST analysis.
Conclusions and future perspectives
The comprehensive computational workflow introduced here enables effective exploration of biosynthetic diversity across large strain collections, pan-genomes of entire bacterial or fungal genera, and metagenomic datasets with thousands of metagenome-assembled genomes. The combined BiG-SCAPE/CORASON platform overcomes key computational bottlenecks inherent in previous approaches, as it facilitates building GCFs with both partial and complete BGCs, accounts for class-specific differences between BGCs, incorporates sequence identify information within limited compute time, charts out evolutionary relationships between and within GCFs, and provides an interactive user interface to explore the outputs. Hence, we anticipate that it will soon facilitate metabologenomic correlation studies to systematically assign many gene clusters to many molecules at unprecedented scales. Additionally, the ability to perform phylogenetic analyses of large sets of complete BGCs, as well as their individual genetic components, a long-standing challenge that has remained unsolved since first posed by Fischbach, Walsh and Clardy in 2008 41 , will constitute a key technology to facilitate fundamental studies on the evolutionary origins of natural product chemical innovations. For example, it provides a stepping-stone to perform detailed analyses of how gene cluster architectures have evolved (and are evolving) from their constituent independent enzymes and sub-clusters. A logical next step will be the unified classification of the millions of BGCs within publicly available genome sequences, and a Pfam-like database for the assignment of biosynthetic gene cluster families to known and unknown areas of natural product chemical diversity.
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